Provided by Tiger Fintech (Singapore) Pte. Ltd.

AxoGen

15.57
-0.0100-0.06%
Post-market: 15.570.00000.00%19:02 EDT
Volume:490.66K
Turnover:7.65M
Market Cap:690.43M
PE:-69.16
High:15.80
Open:15.51
Low:15.27
Close:15.58
Loading ...

Strength Across Segments to Help CAH Stock Offset OptumRx Headwind?

Zacks
·
05 Dec 2024

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Zacks
·
04 Dec 2024

Top Premarket Decliners

MT Newswires Live
·
04 Dec 2024

Are Medical Stocks Lagging Doximity (DOCS) This Year?

Zacks
·
03 Dec 2024

All You Need to Know About AxoGen (AXGN) Rating Upgrade to Buy

Zacks
·
29 Nov 2024

Leerink Partners Reaffirms Their Buy Rating on AxoGen (AXGN)

TIPRANKS
·
28 Nov 2024

How Much Upside is Left in AxoGen (AXGN)? Wall Street Analysts Think 31.18%

Zacks
·
25 Nov 2024

Axogen Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
09 Nov 2024

AxoGen Reports Strong Q3 2024 Revenue Growth

TipRanks
·
08 Nov 2024

Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements

GuruFocus.com
·
08 Nov 2024

AxoGen’s Strong Q3 Performance and Strategic Outlook Underpin Buy Rating

TIPRANKS
·
08 Nov 2024

Stock Track | AxoGen Stock Plunges Despite Solid Q3 Results and Outlook

Stock Track
·
07 Nov 2024

AxoGen Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
07 Nov 2024

AxoGen: Q3 Earnings Snapshot

Associated Press Finance
·
07 Nov 2024

BRIEF-Axogen Reports Q3 2024 Financial Results And Provides BLA Update

Reuters
·
07 Nov 2024

AxoGen reports Q3 adjusted EPS 7c, consensus 1c

TIPRANKS
·
07 Nov 2024

AxoGen reiterates FY24 revenue view of $182M-$186M, consensus $184.72M

TIPRANKS
·
07 Nov 2024

Axogen Maintains 2024 Revenue Guidance Of $182M-$186M Vs. $184.718M Est., And Now Expect To Be At The High End Of 74-76% 2024 Gross Margin Range. Additionally, Reiterates The Company's Expectation To Be Net Cash Flow Positive Cumulatively For The Period From April 1 Through Year End

Benzinga
·
07 Nov 2024

Axogen Q3 2024 Adj EPS $0.07 Beats $0.01 Estimate, Sales $48.64M Beat $47.07M Estimate

Benzinga
·
07 Nov 2024

AxoGen Q3 Revenue USD 48.6 Million VS. Ibes Estimate USD 47.1 Million

THOMSON REUTERS
·
07 Nov 2024